Literature DB >> 11690703

Rapid changes in alcoholic hepatitis histology under steroids: correlation with soluble intercellular adhesion molecule-1 in hepatic venous blood.

L Spahr1, L Rubbia-Brandt, J Pugin, E Giostra, J L Frossard, B Borisch, A Hadengue.   

Abstract

BACKGROUND/AIMS: In alcoholic hepatitis (AH), enhanced expression of intercellular adhesion molecule-1 (ICAM-1) correlates to neutrophil infiltration and histology. In severe AH under steroids, the evolution of the hepatocyte membranous ICAM-1 expression and its soluble form (sICAM-1) is not known.
METHODS: Twenty-six consecutive patients with biopsy-proven severe AH had liver tissue studies for hepatocyte membranous ICAM-1 expression by immunostaining. Lobular neutrophils (mean per high power field) were counted after chloracetate esterase staining. Histological damage was assessed semiquantitatively. Circulating levels of sICAM-1 and TNFalpha in peripheral and hepatic vein were measured using immunoassays. After 8 days on steroids, 19 patients had repeat biopsy.
RESULTS: At baseline, hepatocyte membranous ICAM-1 correlated both to histology (r=0.55, P<0.01) and to lobular neutrophils (r=0.56, P<0.01). On steroids, sICAM-1 in hepatic vein and TNFalpha in both vascular beds decreased. Hepatocyte membranous ICAM-1 and hepatocellular damage decreased, but lobular neutrophils increased. Changes in sICAM-1 in hepatic vein correlated to histological changes (r=0.68, P<0.01).
CONCLUSIONS: In severe AH under steroids, the short term histological improvement was associated with a decrease in circulating TNFalpha, a decrease in ICAM-1 expression, and correlated to hepatic vein sICAM-1 changes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11690703     DOI: 10.1016/s0168-8278(01)00190-8

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  24 in total

Review 1.  Hepatic stellate cells and innate immunity in alcoholic liver disease.

Authors:  Yang-Gun Suh; Won-Il Jeong
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  Corticosteroids and pentoxifylline for the treatment of alcoholic hepatitis: Current status.

Authors:  Ashwani K Singal; Ishmeet Walia; Anjna Singal; Roger D Soloway
Journal:  World J Hepatol       Date:  2011-08-27

Review 3.  Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?

Authors:  Wonhyo Seo; Won-Il Jeong
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 4.  Current and future anti-fibrotic therapies for chronic liver disease.

Authors:  Don C Rockey
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

Review 5.  Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?

Authors:  Moon-Sun Kim; Madeleine Ong; Xianqin Qu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

6.  Sequential therapy consisting of glucocorticoid infusions followed by granulocyte-monocyte absorptive apheresis in patients with severe alcoholic hepatitis.

Authors:  Kazuhiro Watanabe; Yoshihito Uchida; Kayoko Sugawara; Kayoko Naiki; Mie Inao; Nobuaki Nakayama; Satoshi Mochida
Journal:  J Gastroenterol       Date:  2016-11-17       Impact factor: 7.527

Review 7.  Mitochondria and redox signaling in steatohepatitis.

Authors:  E Matthew Morris; R Scott Rector; John P Thyfault; Jamal A Ibdah
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

8.  Treatment of alcoholic liver disease.

Authors:  Thomas H Frazier; Abigail M Stocker; Nicole A Kershner; Luis S Marsano; Craig J McClain
Journal:  Therap Adv Gastroenterol       Date:  2011-01       Impact factor: 4.409

9.  Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis.

Authors:  R P Mookerjee; S Sen; N A Davies; S J Hodges; R Williams; R Jalan
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

10.  Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best?

Authors:  Mercedes Amieva-Balmori; Scherezada María Isabel Mejia-Loza; Roberto Ramos-González; Felipe Zamarripa-Dorsey; Eli García-Ruiz; Nuria Pérez Y López; Eumir I Juárez-Valdés; Adriana López-Luria; José María Remes-Troche
Journal:  World J Hepatol       Date:  2015-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.